The therapy delivered by the HeartStart FR2+ is the most proven in the industry. More than 40 studies confirm its effectiveness. Philips’ high-current/low energy therapy ensures a potent defibrillation dose, while at the same time, minimizing side effects that may be harmful to a fragile heart. So the HeartStart FR2+ can deliver its most powerful therapy from the very first shock. There’s no need to hold back.
Capabilities and Features:
- Automated defibrillation, with manual override (ECG model only)
- SMART Analysis
- SMART CPR and Quick Shock
- Infant/child defibrillation
- Conscious monitoring with optional FR2+ ECG Assessment Module
- Optional rechargeable battery
- Two display options: text-only, and text with ECG
- Voice and text prompts
- Over 8 hours of data collection
- Programmable voice recording
- Automated self-tests
- "Ready-for-Use" indicator
- Long-life battery: 300 shocks (minimum) or 12 hours monitoring
- Pads can connect to most ALS defibrillator/monitors via pads adapters
MEDICAL
DISCLAIMER
"The sale of this item may be subject to
regulation by the U.S. food and drug administration and state and local
regulatory agencies. If so, you must be an authorized purchaser. If the item is
subject to FDA regulation, I will verify your status as an authorized purchaser
of this item before shipping of the item. Regardless of the origin of this
equipment, documentation provided or identification appearing upon the
equipment, the equipment described and offered here is in no way certified for,
recommended for, or offered for any specific use. The purchaser agrees that the
seller shall not be held responsible or liable for any injuries or damages,
whether incidental or coincidental, associated in any way with the equipment.
The purchaser, by bidding or buying this equipment, indicates their knowledge
of, and agreement to the terms of this disclaimer."
